We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (219)
- Scheduling (national classification system) (59)
- Manufacturing (28)
- Advertising (22)
- Unique Device Identification (UDI) hub (21)
- Safety monitoring and information (17)
- Compliance and enforcement (15)
- Clinical trials (10)
- Vaping hub (9)
- Legislation (8)
- Medicinal cannabis hub (5)
- Shortages and supply disruptions (3)
- Breast implant hub (2)
- Cosmetics (1)
- Import and export (1)
- Labelling and packaging (1)
Search
465 result(s) found, displaying 176 to 200
-
Committee meetingsAdvisory Committee on Medical Devices (ACMD) meeting
-
-
Committee meetingsThe 35th meeting of the Advisory Committee on Vaccines (ACV), August 2022.
-
WebinarsInformation for manufacturers, sponsors and users of UDI data on how to access the AusUDID Sandpit
-
PresentationsTo raise awareness and engage with potential website users about the TGA website redevelopment and release.
-
Committee meetingsThe 34th meeting of the Advisory Committee on Vaccines (ACV), July 2022.
-
Unique Device Identification Webinar #10 – Accessing and using the Australian UDI database 'Sandpit'
PresentationsInformation for manufacturers, sponsors and users of UDI data on how to access the AusUDID Sandpit. -
Committee meetingsThe 31st joint meeting of the Advisory Committees on Medicines Scheduling and Chemicals Scheduling (Joint ACMS-ACCS #31), June 2022.
-
Committee meetingsThe 38th meeting of the Advisory Committee on Medicines Scheduling (ACMS #38), June 2022.
-
Committee meetingsThe 34th meeting of the Advisory Committee on Chemicals Scheduling (ACCS #34), June 2022.
-
Committee meetingsAdvisory Committee on Medical Devices (ACMD) meeting
-
-
PresentationsSignificant safety issue reporting - Changes to the Pharmacovigilance guidelines for sponsors.
-
PresentationsImproving healthcare with data collected from medicine and vaccine adverse event reporting.
-
PresentationsReal world evidence in the regulation of medical devices.
-
PresentationsA presentation on current activities, collaborations, and performance of the Prescription Medicine Authorisation Branch.
-
PresentationsPost Market Surveillance - Considerations for medial device sponsors.
-
PresentationsThe increasing availability of Real World Evidence presents opportunities to improve treatments and repurpose medicines.
-
PresentationsUpdates on regulatory framework and key activities from the TGA's Medical Devices Authorisation Branch.
-
PresentationsUpdates on regulatory pathways for gene therapy products in Australia.
-
PresentationsUpdates on key activities for the TGA's Manufacturing Quality Branch.
-
PresentationsUpdates on current activities and focus areas for the Complementary and Over the Counter Medicines Branch.
-
PresentationsLessons learnt from COVID-19 to improve future vaccine development.
-
PresentationsCurrent progress in establishing the Australian Unique Device Identification (UDI) System.
-
PresentationsCurrent considerations for regulating the design and development of software based medical devices.